Beating earnings estimates typically has a positive impact on investor sentiment and can lead to a short-term increase in stock price. The better-than-expected loss per share indicates that Revolution Medicines is performing above analyst expectations, which could lead to increased investor confidence and potentially a rise in the stock's value in the short term.